Myocarditis and Pericarditis

Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-Infected pneumonia in Wuhan, China

Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148 · see citing works

Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.

McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 19,618 · see citing works

Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867 · see citing works

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429 · see citing works

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066 · see citing works

Innate immune recognition

Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394 · see citing works

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hú, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,967 · see citing works

Gout-associated uric acid crystals activate the NALP3 inflammasome

Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326 · see citing works

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001282 · Cited by 5,187 · see citing works

Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China

Shi, S., Qin, M., Shen, B., Cai, Y., Liu, T., Yang, F., Gong, W., Liu, X., Liang, J., Zhao, Q., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.0950 · Cited by 4,349 · see citing works

Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine

Mann, D. L., Zipes, D. P., Libby, P., Bonow, R. O., & D, E. B. M. (2011) · Medical Entomology and Zoology · Cited by 3,745 · see citing works

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

Brahmer, J. R., Lacchetti, C., Schneider, B. J., Atkins, M. B., Brassil, K. J., Caterino, J. M., Chau, I., Ernstoff, M. S., Gardner, J. M., Ginex, P., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.77.6385 · Cited by 3,713 · see citing works

Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

Caforio, A. L. P., Pankuweit, S., Arbustini, E., Basso, C., Gimeno-Blanes, J., Felix, S. B., Fu, M., Heliö, T., Heymans, S., Jahns, R., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht210 · Cited by 3,479 · see citing works

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America

Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000509 · Cited by 3,109 · see citing works

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

Authors Task Force Members, Camm, A. J., Lip, G. Y. H., Caterina, R. D., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P. F., Bax, J. J., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs253 · Cited by 2,898 · see citing works

Effective treatment of severe COVID-19 patients with tocilizumab

Xu, X., Han, M., Li, T., Sun, W., Wang, D., Fu, B., Zhou, Y., Zheng, X., Yang, Y., Li, X., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2005615117 · Cited by 2,636 · see citing works

2015 ESC Guidelines for the diagnosis and management of pericardial diseases

Adler, Y., Charron, P., Imazio, M., Badano, L. P., Barón‐Esquivias, G., Bogaert, J. G., Brucato, A. L., Guéret, P., Klingel, K., Lionis, C. D., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv318 · Cited by 2,635 · see citing works

Covid-19 in Critically Ill Patients in the Seattle Region — Case Series

Bhatraju, P. K., Ghassemieh, B. J., Nichols, M., Kim, R., Jerome, K. R., Nalla, A. K., Greninger, A. L., Pipavath, S. N. J., Wurfel, M. M., Evans, L., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2004500 · Cited by 2,588 · see citing works

Fulminant Myocarditis with Combination Immune Checkpoint Blockade

Johnson, D. B., Balko, J. M., Compton, M. L., Chalkias, S., Gorham, J., Xu, Y., Hicks, M., Puzanov, I., Alexander, M. R., Bloomer, T. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1609214 · Cited by 2,308 · see citing works

Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation

Ferreira, V. M., Schulz-Menger, J., Holmvang, G., Kramer, C. M., Carbone, I., Sechtem, U., Kindermann, I., Gutberlet, M., Cooper, L. T., Liu, P., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.072 · Cited by 2,059 · see citing works

Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic

Driggin, E., Madhavan, M. V., Bikdeli, B., Chuich, T., Laracy, J. C., Biondi‐Zoccai, G., Brown, T. S., Der-Nigoghossian, C. A., Zidar, D. A., Haythe, J. H., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.031 · Cited by 2,037 · see citing works

Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus

Kurt-Jones, E., Popova, L., Kwinn, L. A., Haynes, L., Jones, L. P., Tripp, R., Walsh, E., Freeman, M., Golenbock, D., Anderson, L., et al. (2000) · Nature Immunology · doi:10.1038/80833 · Cited by 1,842 · see citing works

2016 ESC Position Paper on Cancer Treatments and Cardiovascular Toxicity Developed Under the Auspices of the ESC Committee for Practice Guidelines

Zamorano, J. L., Lancellotti, P., Muñoz, D. R., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.654 · Cited by 1,794 · see citing works

Diuretic Strategies in Patients with Acute Decompensated Heart Failure

Felker, G. M., Lee, K. L., Bull, D. A., Redfield, M. M., Stevenson, L. W., Goldsmith, S. R., LeWinter, M. M., Deswal, A. M., Rouleau, J. L., Ofili, E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1005419 · Cited by 1,729 · see citing works

Myocarditis in Patients Treated With Immune Checkpoint Inhibitors

Mahmood, S. S., Fradley, M. G., Cohen, J. V., Nohria, A., Reynolds, K. L., Heinzerling, L. M., Sullivan, R. J., Damrongwatanasuk, R., Chen, C. L., Gupta, D., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.037 · Cited by 1,608 · see citing works

Innate immune recognition: mechanisms and pathways

Medzhitov, R., & Janeway, C. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.917309.x · Cited by 1,589 · see citing works

Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses

Sheahan, T. P., Sims, A. M., Graham, R. L., Menachery, V. D., Gralinski, L. E., Case, J. B., Leist, S. R., Pyrć, K., Feng, J. Y., Trantcheva, I., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal3653 · Cited by 1,575 · see citing works

Guidelines on the Diagnosis and Management of Pericardial Diseases Executive Summary

Maisch, B., Seferovic', P. M., Ristić, A. D., Erbel, R. M., Rienmüller, R., Adler, Y., Tomkowski, W. Z., Thiene, G., Yacoub, M. H., Priori, S. G., et al. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.02.002 · Cited by 1,341 · see citing works

Myocarditis

Cooper, L. T. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0800028 · Cited by 1,317 · see citing works

A Clinical Trial of Immunosuppressive Therapy for Myocarditis

Mason, J. W., O'Connell, J. B., Herskowitz, A., Rose, N. R., McManus, B. M., Billingham, M. E., & Moon, T. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508033330501 · Cited by 1,274 · see citing works

Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases

Pinto, Y. M., Elliot, P. M., Arbustini, E., Adler, Y., Anastasakis, A., Böhm, M., Duboc, D., Gimeno, J. R., de Groote, P., Imazio, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv727 · Cited by 1,098 · see citing works

Recommendations for competitive sports participation in athletes with cardiovascular disease: A consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology

Pelliccia, A. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi325 · Cited by 983 · see citing works

Myocarditis

Feldman, A. M., & McNamara, D. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431908 · Cited by 962 · see citing works

Sudden Death in Young Adults: A 25-Year Review of Autopsies in Military Recruits

Eckart, R. E., Scoville, S. L., Campbell, C. L., Shry, E. A., Stajduhar, K. C., Potter, R. N., Pearse, L. A., & Virmani, R. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-11-200412070-00005 · Cited by 916 · see citing works

Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc

Anthony, R. M., Nimmerjahn, F., Ashline, D. J., Reinhold, V. N., Paulson, J. C., & Ravetch, J. V. (2008) · Science · doi:10.1126/science.1154315 · Cited by 849 · see citing works

Idiopathic Giant-Cell Myocarditis — Natural History and Treatment

Cooper, L. T., Berry, G. J., & Shabetai, R. W. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706263362603 · Cited by 753 · see citing works

Mechanism of NLRP3 inflammasome activation

Sutterwala, F. S., Haasken, S., & Cassel, S. L. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12458 · Cited by 736 · see citing works

2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary

Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.053 · Cited by 685 · see citing works

Detection of viruses in myocardial tissues by polymerase chain reaction

Bowles, N. E., Ni, J., Kearney, D. L., Pauschinger, M., Schultheiß, H., McCarthy, R. E., Hare, J. M., Bricker, J. T., Bowles, K. R., & Towbin, J. A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00648-x · Cited by 668 · see citing works

Colchicine in Addition to Conventional Therapy for Acute Pericarditis: Results of the COlchicine for acute PEricarditis (COPE) Trial

Imazio, M., Bobbio, M., Cecchi, E., Demarie, D., Demichelis, B., Pomari, F., Moratti, M., Gaschino, G., Giammaria, M., Ghisio, A., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.542738 · Cited by 614 · see citing works

A Randomized Trial of Colchicine for Acute Pericarditis

Imazio, M., Brucato, A., Cemin, R., Ferrua, S., Maggiolini, S., Beqaraj, F., Demarie, D., Forno, D., Ferro, S., Maestroni, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208536 · Cited by 611 · see citing works

Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study

Frustaci, A., Russo, M. A., & Chimenti, C. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp249 · Cited by 604 · see citing works

Viral Persistence in the Myocardium Is Associated With Progressive Cardiac Dysfunction

Kühl, U., Pauschinger, M., Seeberg, B., Laßner, D., Noutsias, M., Poller, W. C., & Schultheiß, H. (2005) · Circulation · doi:10.1161/circulationaha.105.548156 · Cited by 599 · see citing works

Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome

Hendren, N. S., Drazner, M. H., Bozkurt, B., & Cooper, L. T. (2020) · Circulation · doi:10.1161/circulationaha.120.047349 · Cited by 576 · see citing works

Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy

Badorff, C., Lee, G.-H., Lamphear, B. J., Martone, M. E., Campbell, K. P., Rhoads, R. E., & Knowlton, K. U. (1999) · Nature Medicine · doi:10.1038/6543 · Cited by 574 · see citing works

Controlled Trial of Intravenous Immune Globulin in Recent-Onset Dilated Cardiomyopathy

McNamara, D. M., Holubkov, R., Starling, R. C., Dec, G. W., Loh, E., Torre‐Amione, G., Gass, A. L., Janosko, K. M., Tokarczyk, T. R., Kessler, P., et al. (2001) · Circulation · doi:10.1161/01.cir.103.18.2254 · Cited by 557 · see citing works

The Variety of Cardiovascular Presentations of COVID-19

Fried, J., Ramasubbu, K., Bhatt, R., Topkara, V. K., Clerkin, K. J., Horn, E. M., Rabbani, L. E., Brodie, D., Jain, S. S., Kirtane, A. J., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.047164 · Cited by 546 · see citing works

Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy

Heinzerling, L., Ott, P. A., Hodi, F. S., Husain, A. N., Tajmir-Riahi, A., Tawbi, H., Pauschinger, M., Gajewski, T. F., Lipson, E. J., & Luke, J. J. (2016) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-016-0152-y · Cited by 511 · see citing works

Anti‐mitotic activity of colchicine and the structural basis for its interaction with tubulin

Bhattacharyya, B., Panda, D., Gupta, S., & Banerjee, M. (2008) · Medicinal Research Reviews · doi:10.1002/med.20097 · Cited by 499 · see citing works

Diuretic Therapy for Patients With Heart Failure

Felker, G. M., Ellison, D. H., Müllens, W., Cox, Z. L., & Testani, J. M. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.12.059 · Cited by 460 · see citing works

Randomized, Placebo-Controlled Study for Immunosuppressive Treatment of Inflammatory Dilated Cardiomyopathy

Wojnicz, R., Nowalany-Kozielska, E., Wojciechowska, C., Glanowska, G., Wilczewski, P., Niklewski, T., Zembala, M., Poloński, L., Rozek, M. M., & Wodniecki, J. (2001) · Circulation · doi:10.1161/01.cir.104.1.39 · Cited by 455 · see citing works

Colchicine as First-Choice Therapy for Recurrent Pericarditis

Imazio, M., Bobbio, M., Cecchi, E., Demarie, D., Pomari, F., Moratti, M., Ghisio, A., Belli, R., & Trinchero, R. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.17.1987 · Cited by 423 · see citing works

Sudden unexpected death in persons <40 years of age

Drory, Y., Turetz, Y., Hiss, Y., Lev, B. I., Fisman, E. Z., Pines, A., & Kramer, M. R. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90251-f · Cited by 422 · see citing works

Controversial Issues in the Management of Pericardial Diseases

Imazio, M., Spodick, D. H., Brucato, A. L., Trinchero, R., & Adler, Y. (2010) · Circulation · doi:10.1161/circulationaha.108.844753 · Cited by 412 · see citing works

Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic

Welt, F. G. P., Shah, P. B., Aronow, H. D., Bortnick, A. E., Henry, T. D., Sherwood, M. W., Young, M. N., Davidson, L. J., Kadavath, S., Mahmud, E., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.021 · Cited by 411 · see citing works

Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial

Imazio, M., Belli, R., Brucato, A. L., Cemin, R., Ferrua, S., Beqaraj, F., Demarie, D., Ferro, S., Forno, D., Maestroni, S., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62709-9 · Cited by 406 · see citing works

Colchicine for Recurrent Pericarditis (CORP)

Imazio, M., Brucato, A. L., Cemin, R., Ferrua, S., Belli, R., Maestroni, S., Trinchero, R., Spodick, D. H., & Adler, Y. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-7-201110040-00359 · Cited by 389 · see citing works

Molecular Biology and Pathogenesis of Viral Myocarditis

Esfandiarei, M., & McManus, B. M. (2008) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.151534 · Cited by 387 · see citing works

A Prospective, Randomized, Controlled Trial of Prednisone for Dilated Cardiomyopathy

Parrillo, J. E., Cunnion, R. E., Epstein, S. E., Parker, M. M., Suffredini, A. F., Brenner, M., Schaer, G. L., Palmeri, S. T., Cannon, R. O., Alling, D. W., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198910193211601 · Cited by 352 · see citing works

Cyclooxygenase Enzymes: Regulation and Function

Fitzpatrick, F. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043453144 · Cited by 340 · see citing works

Interleukin-17A Is Dispensable for Myocarditis but Essential for the Progression to Dilated Cardiomyopathy

Baldeviano, G. C., Barin, J. G., Talor, M. V., Srinivasan, S., Bedja, D., Zheng, D., Gabrielson, K., Iwakura, Y., Rose, N. R., & Cihakova, D. (2010) · Circulation Research · doi:10.1161/circresaha.109.213157 · Cited by 334 · see citing works

A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction

Kodama, M., Matsumoto, Y., Fujiwara, M., Masani, F., Izumi, T., & Shibata, A. (1990) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(90)90039-s · Cited by 330 · see citing works

From Infection to Autoimmunity

Fairweather, D., Kaya, Z., Shellam, G. R., Lawson, C. M., & Rose, N. R. (2001) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0492 · Cited by 328 · see citing works

Acute Pericarditis

Lange, R. A., & Hillis, L. D. (2004) · New England Journal of Medicine · doi:10.1056/nejmcp041997 · Cited by 328 · see citing works

Sex and Gender Differences in Myocarditis and Dilated Cardiomyopathy

Fairweather, D., Cooper, L. T., & Blauwet, L. A. (2013) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2012.07.003 · Cited by 325 · see citing works

B‐cell activation influences T‐cell polarization and outcome of anti‐CD20 B‐cell depletion in central nervous system autoimmunity

Weber, M. S., Prod’homme, T., Patarroyo, J. C., Molnarfi, N., Karnezis, T., Lehmann‐Horn, K., Danilenko, D. M., Eastham‐Anderson, J., Slavin, A., Linington, C., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22081 · Cited by 321 · see citing works

The Spectrum of Serious Infections Among Patients Receiving Immune Checkpoint Blockade for the Treatment of Melanoma

Castillo, M. D., Romero, F. A. R., Argüello, E., Kyi, C., Postow, M. A., & Redelman‐Sidi, G. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw539 · Cited by 292 · see citing works

Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor–Associated Myocarditis

Zhang, L., Zlotoff, D. A., Awadalla, M., Mahmood, S., Nohria, A., Hassan, M. Z. O., Thuny, F., Zubiri, L., Chen, C. L., Sullivan, R. J., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044703 · Cited by 285 · see citing works

Management of Myocarditis-Related Cardiomyopathy in Adults

Tschöpe, C., Cooper, L. T., Torre‐Amione, G., & Linthout, S. V. (2019) · Circulation Research · doi:10.1161/circresaha.118.313578 · Cited by 280 · see citing works

Myopericarditis versus viral or idiopathic acute pericarditis

Imazio, M., Cecchi, E., Demichelis, B., Chinaglia, A., Ierna, S., Demarie, D., Ghisio, A., Pomari, F., Belli, R., & Trinchero, R. (2007) · Heart · doi:10.1136/hrt.2006.104067 · Cited by 267 · see citing works

Molecular Biology and Pathogenesis of Viral Myocarditis

Esfandiarei, M., & McManus, B. M. (2007) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.3.121806.151534 · Cited by 259 · see citing works

High Prevalence of Cardiac Parvovirus B19 Infection in Patients With Isolated Left Ventricular Diastolic Dysfunction

Tschöpe, C., Bock, C. –., Kasner, M., Noutsias, M., Westermann, D., Schwimmbeck, P. L., Pauschinger, M., Poller, W. C., Kühl, U., Kandolf, R., et al. (2005) · Circulation · doi:10.1161/01.cir.0000155615.68924.b3 · Cited by 258 · see citing works

Nitric oxide inhibits viral replication in murine myocarditis.

Lowenstein, C. J., Hill, S. L., Lafond-Walker, A., Wu, J. M., Allen, G., Landavere, M. G., Rose, N. R., & Herskowitz, A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118613 · Cited by 251 · see citing works

Clinical and Demographic Predictors of Outcomes in Recent Onset Dilated Cardiomyopathy

McNamara, D. M., Starling, R. C., Cooper, L. T., BOEHMER, J. P., Mather, P. J., Janosko, K. M., Gorcsan, J., Kip, K. E., & Dec, G. W. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.05.033 · Cited by 242 · see citing works

Intravenous Immune Globulin in the Therapy of Myocarditis and Acute Cardiomyopathy

McNamara, D. M., Rosenblum, W. D., Janosko, K. M., Trost, M. K., Villaneuva, F. S., Demetris, A. J., Murali, S., & Feldman, A. M. (1997) · Circulation · doi:10.1161/01.cir.95.11.2476 · Cited by 237 · see citing works

Sudden cardiac death in Air Force recruits. A 20-year review

Phillips, M. (1986) · JAMA · doi:10.1001/jama.256.19.2696 · Cited by 236 · see citing works

Cardiac myosin-Th17 responses promote heart failure in human myocarditis

Myers, J. M., Cooper, L. T., Kem, D. C., Stavrakis, S., Kosanke, S. D., Shevach, E. M., Fairweather, D., Stoner, J. A., Cox, C. J., & Cunningham, M. W. (2016) · JCI Insight · doi:10.1172/jci.insight.85851 · Cited by 230 · see citing works

Cardiovascular Toxicities of Immune Checkpoint Inhibitors

Ball, S., Ghosh, R. K., Wongsaengsak, S., Bandyopadhyay, D., Ghosh, G. C., Aronow, W. S., Fonarow, G. C., Lenihan, D. J., & Bhatt, D. L. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.07.079 · Cited by 229 · see citing works

IL-12 Receptor β1 and Toll-Like Receptor 4 Increase IL-1β- and IL-18-Associated Myocarditis and Coxsackievirus Replication

Fairweather, D., Yusung, S., Frisancho, S., Barrett, M., Gatewood, S., Steele, R., & Rose, N. R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4731 · Cited by 229 · see citing works

Modes of action of aspirin-like drugs.

Abramson, S. B., Korchak, H. M., Ludewig, R., Edelson, H. S., HAINES, K. A., Levin, R. I., Herman, R., Rider, L. G., Kimmel, S. C., & Weissmann, G. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.21.7227 · Cited by 219 · see citing works

Cutting Edge: Cross-Regulation by TLR4 and T cell Ig Mucin-3 Determines Sex Differences in Inflammatory Heart Disease

Frisancho-Kiss, S., Davis, S. E., Nyland, J. F., Frisancho, J. A., Cihakova, D., Barrett, M. A., Rose, N. R., & Fairweather, D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6710 · Cited by 212 · see citing works

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

Camm, A. J., Lip, G. Y. H., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P., ESC Committee for Practice Guidelines, C., Bax, J. J., et al. (2012) · doi:10.48350/15016 · Cited by 205 · see citing works

Interferon-γ Protects against Chronic Viral Myocarditis by Reducing Mast Cell Degranulation, Fibrosis, and the Profibrotic Cytokines Transforming Growth Factor-β1, Interleukin-1β, and Interleukin-4 in the Heart

Fairweather, D., Frisancho-Kiss, S., Yusung, S. A., Barrett, M. A., Davis, S. E., Gatewood, S. J. L., Njoku, D. B., & Rose, N. R. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63241-5 · Cited by 198 · see citing works

An animal model of congestive (dilated) cardiomyopathy: dilatation and hypertrophy of the heart in the chronic stage in DBA/2 mice with myocarditis caused by encephalomyocarditis virus.

Matsumori, A., & Kawai, C. (1982) · Circulation · doi:10.1161/01.cir.66.2.355 · Cited by 193 · see citing works

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations

Maron, B. J., Zipes, D. P., & Kovacs, R. J. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.09.032 · Cited by 191 · see citing works

Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption

Felix, S. B., Staudt, A., Landsberger, M., Große, Y., Stangl, V., Spielhagen, T., Wallukat, G., Wernecke, K. D., Baumann, G., & Stangl, K. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01794-6 · Cited by 189 · see citing works

Autoantibodies in Heart Failure and Cardiac Dysfunction

Kaya, Z., Leib, C., & Katus, H. A. (2012) · Circulation Research · doi:10.1161/circresaha.111.243360 · Cited by 189 · see citing works

A Role for Toll-like Receptor 3 Variants in Host Susceptibility to Enteroviral Myocarditis and Dilated Cardiomyopathy

Gorbea, C. M., Makar, K. A., Pauschinger, M., Pratt, G. W., Bersola, J., Varela, J. J., David, R. M., Banks, L. D., Huang, C., Li, H., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.047464 · Cited by 188 · see citing works

Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury.

Chow, L. H., Beisel, K. W., & McManus, B. M. (1992) · PubMed · Cited by 187 · see citing works

Contribution of the innate immune system to autoimmune myocarditis: a role for complement

Kaya, Z., Afanasyeva, M., Wang, Y., Dohmen, K. M., Schlichting, J., Tretter, T., Fairweather, D., Holers, V. M., & Rose, N. R. (2001) · Nature Immunology · doi:10.1038/90686 · Cited by 175 · see citing works

Pancreatic expression of interferon-γ protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis

Horwitz, M. S., Cava, A. L., Fine, C., Rodriguez, E., Ilic, A., & Sarvetnick, N. (2000) · Nature Medicine · doi:10.1038/76277 · Cited by 166 · see citing works

Update on coxsackievirus B3 myocarditis

Fairweather, D., Stafford, K. A., & Sung, Y. K. (2012) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328353372d · Cited by 165 · see citing works

Colchicine and the Heart

Deftereos, S., Giannopoulos, G., Papoutsidakis, N., Panagopoulou, V., Kossyvakis, C., Raisakis, K., Cleman, M. W., & Stefanadis, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.08.726 · Cited by 161 · see citing works

Protective Role for Interferon-β in Coxsackievirus B3 Infection

Deonarain, R., Cerullo, D., Fuse, K., Liu, P. P., & Fish, E. N. (2004) · Circulation · doi:10.1161/01.cir.0000136824.73458.20 · Cited by 160 · see citing works

Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-β treatment in patients with chronic viral cardiomyopathy

Schultheiß, H., Piper, C., Sowade, O., Waagstein, F., Kapp, J. F., Wegscheider, K., Groetzbach, G., Pauschinger, M., Escher, F., Arbustini, E., et al. (2016) · Clinical Research in Cardiology · doi:10.1007/s00392-016-0986-9 · Cited by 143 · see citing works

Pathogenesis and diagnosis of myocarditis

ElAmm, C. A., Fairweather, D., & Cooper, L. T. (2012) · Heart · doi:10.1136/heartjnl-2012-301686 · Cited by 140 · see citing works

Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon

Kandolf, R., Canu, A., & Hofschneider, P. H. (1985) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(85)80019-5 · Cited by 136 · see citing works

Adverse Events Associated with Immune Checkpoint Blockade

Tervaert, J.-W. C., Ye, C., & Yacyshyn, E. (2018) · New England Journal of Medicine · doi:10.1056/nejmc1801663 · Cited by 134 · see citing works

IL-12 Protects against Coxsackievirus B3-Induced Myocarditis by Increasing IFN-γ and Macrophage and Neutrophil Populations in the Heart

Fairweather, D., Frisancho-Kiss, S., Yusung, S. A., Barrett, M. A., Davis, S. E., Steele, R. A., Gatewood, S. J. L., & Rose, N. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.261 · Cited by 133 · see citing works

Late Onset Ipilimumab-Induced Pericarditis and Pericardial Effusion: A Rare but Life Threatening Complication

Yun, S., Vincelette, N. D., Mansour, I. S. M., Hariri, D. J., & Motamed, S. (2015) · Case Reports in Oncological Medicine · doi:10.1155/2015/794842 · Cited by 130 · see citing works

Effects of prednisolone on acute viral myocarditis in mice

Tomioka, N., Kishimoto, C., Matsumori, A., & Kawai, C. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80349-7 · Cited by 129 · see citing works

Murine natural killer cells limit coxsackievirus B3 replication.

Godeny, E. K., & Gauntt, C. J. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.3.913 · Cited by 128 · see citing works

Cancer immunotherapy by targeting immune checkpoints: mechanism of T cell dysfunction in cancer immunity and new therapeutic targets

Tsai, H.-F., & Hsu, P. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0341-0 · Cited by 127 · see citing works

Giant Cell Myocarditis: Diagnosis and Treatment

Cooper, L. T. (2000) · Herz · doi:10.1007/s000590050023 · Cited by 126 · see citing works

A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells

Shafren, D. R., Williams, D. T., & Barry, R. D. (1997) · Journal of Virology · doi:10.1128/jvi.71.12.9844-9848.1997 · Cited by 126 · see citing works

Myeloid Differentiation Factor-88/Interleukin-1 Signaling Controls Cardiac Fibrosis and Heart Failure Progression in Inflammatory Dilated Cardiomyopathy

Błyszczuk, P., Kania, G., Dieterle, T., Marty, R. R., Valaperti, A., Berthonneche, C., Pedrazzini, T., Berger, C. T., Dirnhofer, S., Matter, C. M., et al. (2009) · Circulation Research · doi:10.1161/circresaha.109.199802 · Cited by 122 · see citing works

The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis

Zaragoza, C., Ocampo, C. J., Saura, M., Leppo, M. K., Wei, X., Quick, R. A., Moncada, S., Liew, F. Y., & Lowenstein, C. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2469 · Cited by 122 · see citing works

Testosterone and interleukin-1β increase cardiac remodeling during coxsackievirus B3 myocarditis via serpin A 3n

Coronado, M. J., Brandt, J. E., Kim, E., Bucek, A., Bedja, D., Abston, E. D., Shin, J., Gabrielson, K. L., Mitzner, W., & Fairweather, D. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00783.2011 · Cited by 116 · see citing works

Mast Cells and Innate Cytokines are Associated with Susceptibility to Autoimmune Heart Disease Following Coxsackievirus B3 Infection

Fairweather, D., Frisancho-Kiss, S., Gatewood, S., Njoku, D., Steele, R., Barrett, M., & Rose, N. R. (2004) · Autoimmunity · doi:10.1080/0891693042000196200 · Cited by 115 · see citing works

Age and gender effects on the extent of myocardial involvement in acute myocarditis: a cardiovascular magnetic resonance study

Cocker, M. S., Abdel-Aty, H., Strohm, O., & Friedrich, M. G. (2009) · Heart · doi:10.1136/hrt.2008.164061 · Cited by 115 · see citing works

Respiratory Syncytial Virus Fusion Protein-Induced Toll-Like Receptor 4 (TLR4) Signaling Is Inhibited by the TLR4 Antagonists Rhodobacter sphaeroides Lipopolysaccharide and Eritoran (E5564) and Requires Direct Interaction with MD-2

Rallabhandi, P., Phillips, R. L., Boukhvalova, M. S., Pletneva, L. M., Shirey, K. A., Gioannini, T. L., Weiss, J. P., Chow, J. C., Hawkins, L. D., Vogel, S. N., et al. (2012) · mBio · doi:10.1128/mbio.00218-12 · Cited by 109 · see citing works

Exercise in coxsackie B3 myocarditis: Effects on heart lymphocyte subpopulations and the inflammatory reaction

Ilbäck, N., Fohlman, J., & Friman, G. (1989) · American Heart Journal · doi:10.1016/0002-8703(89)90409-2 · Cited by 107 · see citing works

Spoilt for choice of co-receptors

Clapham, P. R., & Weiss, R. A. (1997) · Nature · doi:10.1038/40758 · Cited by 107 · see citing works

Therapy with cyclosporine in experimental murine myocarditis with encephalomyocarditis virus.

Monrad, E. S., Matsumori, A., Murphy, J. C., Fox, J. G., Crumpacker, C. S., & Abelmann, W. H. (1986) · Circulation · doi:10.1161/01.cir.73.5.1058 · Cited by 107 · see citing works

Blocking the IL-1β signalling pathway prevents chronic viral myocarditis and cardiac remodeling

Kraft, L., Erdenesukh, T., Sauter, M., Tschöpe, C., & Klingel, K. (2019) · Basic Research in Cardiology · doi:10.1007/s00395-019-0719-0 · Cited by 107 · see citing works

Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis

Linthout, S. V., Savvatis, K., Miteva, K., Peng, J., Ringe, J., Warstat, K., Schmidt‐Lucke, C., Sittinger, M., Schultheiss, H. ‐., & Tschöpe, C. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq467 · Cited by 105 · see citing works

Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load

Dennert, R. M., Velthuis, S., Schalla, S. M., Eurlings, L. W. M., van Suylen, R. J., van Paassen, P., Tervaert, J. W. C., Wolffs, P. F. G., Goossens, V. J., Bruggeman, C. A., et al. (2010) · Antiviral Therapy · doi:10.3851/imp1516 · Cited by 104 · see citing works

Immunosuppressive Therapy Improves Both Short- and Long-Term Prognosis in Patients With Virus-Negative Nonfulminant Inflammatory Cardiomyopathy

Merken, J. J., Hazebroek, M. R., van Paassen, P., Verdonschot, J. A. J., van Empel, V. P. M., Knackstedt, C., Hamid, M. A. A., Seiler, M., Kolb, J., Hoermann, P., et al. (2018) · Circulation Heart Failure · doi:10.1161/circheartfailure.117.004228 · Cited by 104 · see citing works

Cardio-Immunology of Myocarditis: Focus on Immune Mechanisms and Treatment Options

Maisch, B. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00048 · Cited by 103 · see citing works

Elevated Sera sST2 Is Associated With Heart Failure in Men ≤50 Years Old With Myocarditis

Coronado, M. J., Bruno, K. A., Blauwet, L. A., Tschöpe, C., Cunningham, M. W., Pankuweit, S., van Linthout, S., Jeon, E., McNamara, D. M., Krejčí, J., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.008968 · Cited by 99 · see citing works

Long-term outcome of patients with virus-negative chronic myocarditis or inflammatory cardiomyopathy after immunosuppressive therapy

Escher, F., Kühl, U., Laßner, D., Poller, W. C., Westermann, D., Pieske, B. M., Tschöpe, C., & Schultheiß, H. (2016) · Clinical Research in Cardiology · doi:10.1007/s00392-016-1011-z · Cited by 97 · see citing works

Th2 Regulation of Viral Myocarditis in Mice: Different Roles for TLR3 versus TRIF in Progression to Chronic Disease

Abston, E. D., Coronado, M. J., Bucek, A., Bedja, D., Shin, J., Kim, J. B., Kim, E., Gabrielson, K. L., Georgakopoulos, D., Mitzner, W., et al. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/129486 · Cited by 94 · see citing works

Cardiovirulent Coxsackieviruses and the Decay-Accelerating Factor (CD55) Receptor

Martino, T. A., Petric, M., Brown, M., AITKEN, K. J., Gauntt, C. J., Richardson, C. D., Chow, L. H., & Liu, P. P. (1998) · Virology · doi:10.1006/viro.1998.9122 · Cited by 93 · see citing works

Long-Term Risk of Recurrence, Morbidity and Mortality in Giant Cell Myocarditis

Maleszewski, J. J., Orellana, V., Hodge, D. O., Kühl, U., Schultheiß, H., & Cooper, L. T. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.03.023 · Cited by 91 · see citing works

Nitric oxide inhibition of coxsackievirus replication in vitro.

Zaragoza, C., Ocampo, C. J., Saura, M., McMillan, A., & Lowenstein, C. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119702 · Cited by 91 · see citing works

NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis

Tschöpe, C., Müller, I., Xia, Y., Savvatis, K., Pappritz, K., Pinkert, S., Lassner, D., Heimesaat, M. M., Spillmann, F., Miteva, K., et al. (2017) · Circulation: Heart Failure · doi:10.1161/circheartfailure.117.003870 · Cited by 88 · see citing works

Coxsackievirus B3 myocarditis in C3H/HeJ mice: Description of an inbred model and the effect of exercise on virulence

Kiel, R. J., Smith, F., Chason, J. L., Khatib, R., & Reyes, M. P. (1989) · European Journal of Epidemiology · doi:10.1007/bf00144836 · Cited by 85 · see citing works

MyD88 Signaling Controls Autoimmune Myocarditis Induction

Marty, R. R., Dirnhofer, S., Mauermann, N., Schweikert, S., Akira, S., Hunziker, L., Penninger, J. M., & Eriksson, U. (2006) · Circulation · doi:10.1161/circulationaha.105.564294 · Cited by 82 · see citing works

Complement Receptor 1 and 2 Deficiency Increases Coxsackievirus B3-Induced Myocarditis, Dilated Cardiomyopathy, and Heart Failure by Increasing Macrophages, IL-1β, and Immune Complex Deposition in the Heart

Fairweather, D., Frisancho-Kiss, S., Njoku, D. B., Nyland, J. F., Kaya, Z., Yusung, S. A., Davis, S. E., Frisancho, J. A., Barrett, M. A., & Rose, N. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3516 · Cited by 82 · see citing works

Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy

Maisch, B., & Pankuweit, S. (2012) · Herz · doi:10.1007/s00059-012-3679-9 · Cited by 80 · see citing works

Treatment of Inflammatory Dilated Cardiomyopathy and (Peri)Myocarditis with Immunosuppression and i.v. Immunoglobulins

Maisch, B., Hufnagel, G., K�lsch, S., Funck, R., Richter, A., Rupp, H., Herzum, M., & Pankuweit, S. (2004) · Herz · doi:10.1007/s00059-004-2628-7 · Cited by 80 · see citing works

TRIF Is a Critical Survival Factor in Viral Cardiomyopathy

Riad, A., Westermann, D., Zietsch, C., Savvatis, K., Becher, P. M., Bereswill, S., Heimesaat, M. M., Lettau, O., Laßner, D., Dörner, A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002029 · Cited by 79 · see citing works

A Systematic Review of COVID-19 and Myocarditis

Kariyanna, P. T., Sutarjono, B., Grewal, E., Singh, K. P., Aurora, L., Smith, L., Chandrakumar, H. P., Jayarangaiah, A., Goldman, S. A., Salifu, M. O., et al. (2020) · American Journal of Medical Case Reports · doi:10.12691/ajmcr-8-9-11 · Cited by 77 · see citing works

Sex and gender differences in myocardial hypertrophy and heart failure

Regitz‐Zagrosek, V., & Seeland, U. (2011) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-011-0892-8 · Cited by 75 · see citing works

TNF-α-Secreting B Cells Contribute to Myocardial Fibrosis in Dilated Cardiomyopathy

Yu, M., Wen, S., Wang, M., Liang, W. H., Li, H., Long, Q., Guo, H.-P., Liao, Y., & Yuan, J. (2013) · Journal of Clinical Immunology · doi:10.1007/s10875-013-9889-y · Cited by 75 · see citing works

Role of human TLR4 in respiratory syncytial virus-induced NF-κB activation, viral entry and replication

Marr, N., & Turvey, S. E. (2012) · Innate Immunity · doi:10.1177/1753425912444479 · Cited by 75 · see citing works

Characterisation of Murine Cytomegalovirus Myocarditis: Cellular Infiltration of the Heart and Virus Persistence

Lenzo, J. C., Fairweather, D., Cull, V., Shellam, G. R., & James(Lawson), C. M. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.2003 · Cited by 74 · see citing works

Mesenchymal stromal cells inhibit NLRP3 inflammasome activation in a model of Coxsackievirus B3-induced inflammatory cardiomyopathy

Miteva, K., Pappritz, K., Sosnowski, M., El-Shafeey, M. E. A., Müller, I., Dong, F., Savvatis, K., Ringe, J., Tschöpe, C., & Linthout, S. V. (2018) · Scientific Reports · doi:10.1038/s41598-018-20686-6 · Cited by 72 · see citing works

IL-33 Independently Induces Eosinophilic Pericarditis and Cardiac Dilation: ST2 Improves Cardiac Function

Abston, E. D., Barin, J. G., Cihakova, D., Bucek, A., Coronado, M. J., Brandt, J. E., Bedja, D., Kim, J. B., Georgakopoulos, D., Gabrielson, K. L., et al. (2012) · Circulation: Heart Failure · doi:10.1161/circheartfailure.111.963769 · Cited by 69 · see citing works

Protective effect of recombinant alpha interferon on coxsackievirus B3 myocarditis in mice

Matsumori, A., Tomioka, N., & Kawai, C. (1988) · American Heart Journal · doi:10.1016/0002-8703(88)90013-0 · Cited by 68 · see citing works

Autoimmune Myocarditis, Valvulitis, and Cardiomyopathy

Myers, J. M., Fairweather, D., Huber, S. A., & Cunningham, M. W. (2013) · Current Protocols in Immunology · doi:10.1002/0471142735.im1514s101 · Cited by 63 · see citing works

Beta-blocker treatment of dilated cardiomyopathy. Beneficial effect of carteolol in mice.

Tominaga, M., Matsumori, A., Okada, I., Yamada, T., & Kawai, C. (1991) · Circulation · doi:10.1161/01.cir.83.6.2021 · Cited by 63 · see citing works

Human Herpesvirus-6: A Short Review of Its Biological Behavior

Krueger, G. R. F., & Ablashi, D. V. (2003) · Intervirology · doi:10.1159/000073205 · Cited by 62 · see citing works

Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19

Ascierto, P. A., Fox, B. A., Urba, W. J., Anderson, A. C., Atkins, M. B., Borden, E. C., Brahmer, J. R., Butterfield, L. H., Cesano, A., Chen, D. S., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000878 · Cited by 61 · see citing works

An angiotensin II receptor antagonist reduces myocardial damage in an animal model of myocarditis.

Tanaka, A., Matsumori, A., Wang, W., & Sasayama, S. (1994) · Circulation · doi:10.1161/01.cir.90.4.2051 · Cited by 60 · see citing works

Treatment options in myocarditis and inflammatory cardiomyopathy

Maisch, B., & Alter, P. J. (2018) · Herz · doi:10.1007/s00059-018-4719-x · Cited by 56 · see citing works

Transplantation for Myocarditis: A Controversy Revisited

Moloney, E. D., Egan, J. J., Kelly, P. J., Wood, A. E., & Cooper, L. T. (2005) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2004.06.015 · Cited by 56 · see citing works

Enhanced expression of superoxide dismutase messenger RNA in viral myocarditis. An SH-dependent reduction of its expression and myocardial injury.

Suzuki, H., Matsumori, A., Matoba, Y., Kyu, B.-S., Tanaka, A., Fujita, J., & Sasayama, S. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116513 · Cited by 56 · see citing works

Viral myocarditis

Linthout, S. V., & Tschöpe, C. (2018) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000515 · Cited by 51 · see citing works

Human cardiac-specific cDNA array for idiopathic dilated cardiomyopathy: sex-related differences

Haddad, G. E., Saunders, L. J., Crosby, S. D., Carles, M., del Monte, F., King, K., Bristow, M. R., Spinale, F. G., MacGillivray, T. E., Semigran, M. J., et al. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00265.2007 · Cited by 50 · see citing works

TLR3 deficiency induces chronic inflammatory cardiomyopathy in resistant mice following coxsackievirus B3 infection: role for IL-4

Abston, E. D., Coronado, M. J., Bucek, A., Onyimba, J. A., Brandt, J. E., Frisancho, J. A., Kim, E., Bedja, D., Sung, Y.-K., Radtke, A. J., et al. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00516.2011 · Cited by 48 · see citing works

Telbivudine in Chronic Lymphocytic Myocarditis and Human Parvovirus B19 Transcriptional Activity

Linthout, S. V., Elsanhoury, A., Klein, O., Sosnowski, M., Miteva, K., Laßner, D., Abou‐El‐Enein, M., Pieske, B. M., Kühl, U., & Tschöpe, C. (2018) · ESC Heart Failure · doi:10.1002/ehf2.12341 · Cited by 48 · see citing works

Exercise induced augmentation of cellular and humoral autoimmunity associated with increased cardiac dilatation in experimental autoimmune myocarditis

Hosenpud, J. D., CAMPBELL, S. M., Niles, N. R., Lee, J. D., MENDELSON, D., & Hart, M. V. (1987) · Cardiovascular Research · doi:10.1093/cvr/21.3.217 · Cited by 46 · see citing works

In vivo deposition of myosin-specific autoantibodies in the hearts of mice with experimental autoimmune myocarditis

Neumann, D. A., Lane, J. R., Wulff, S. M., Allen, G. S., Lafond-Walker, A., Herskowitz, A., & Rose, N. R. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.12.3806 · Cited by 45 · see citing works

Sudden death related myocarditis: a study of 56 cases

Kitulwatte, I. D. G., Kim, P. J. H., & Pollanen, M. S. (2009) · Forensic Science Medicine and Pathology · doi:10.1007/s12024-009-9125-5 · Cited by 45 · see citing works

Controversial Role of Toll-like Receptor 4 in Adult Stem Cells

Zeuner, M., Bieback, K., & Widera, D. (2015) · Stem Cell Reviews and Reports · doi:10.1007/s12015-015-9589-5 · Cited by 44 · see citing works

Sudden unexpected cardiac deaths among young Swedish orienteers — Morphological changes in hearts and other organs

Larsson, E., Wesslén, L., Lindquist, O., BAANDRUR, U., Eriksson, L. G., Olsen, E. G. J., Rolf, C., & Friman, G. (1999) · Apmis · doi:10.1111/j.1699-0463.1999.tb01561.x · Cited by 43 · see citing works

Attenuation of virus-induced myocardial injury by inhibition of the angiotensin II type 1 receptor signal and decreased nuclear factor-kappa B activation in knockout mice

Yamamoto, K., Shioi, T., Uchiyama, K., Miyamoto, T., Sasayama, S., & Matsumori, A. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.07.021 · Cited by 40 · see citing works

Effects of Free Immunoglobulin Light Chains on Viral Myocarditis

Matsumori, A., Shimada, M., Jie, X., Higuchi, H., Kormelink, T. G., & Redegeld, F. A. (2010) · Circulation Research · doi:10.1161/circresaha.110.218438 · Cited by 40 · see citing works

Dilated cardiomyopathy update: infectious-immune theory revisited

Kawai, C., & Matsumori, A. (2013) · Heart Failure Reviews · doi:10.1007/s10741-013-9401-z · Cited by 39 · see citing works

Risks versus Benefits of NSAIDs Including Aspirin in Myocarditis

Meune, C., Spaulding, C. M., Mah, I., Lebon, P., & Bergmann, J. (2003) · Drug Safety · doi:10.2165/00002018-200326130-00005 · Cited by 39 · see citing works

Checkpoint immunotherapy for cancer: superior survival, unaccustomed toxicities

Gedye, C. A., van der Westhuizen, A., & John, T. (2014) · Internal Medicine Journal · doi:10.1111/imj.12653 · Cited by 38 · see citing works

Peroxynitrite inhibition of Coxsackievirus infection by prevention of viral RNA entry

Padalko, E. Y., Ohnishi, T., Matsushita, K., Sun, H., Fox-Talbot, K., Bao, C., Baldwin, W. M., & Lowenstein, C. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400518101 · Cited by 38 · see citing works

Mouse Models of Autoimmune Diseases - Autoimmune Myocarditis

Müller, A., Fischer, A., Katus, H. A., & Kaya, Z. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150316123711 · Cited by 35 · see citing works

Spectrophotometric methods for the determination of Ibuprofen in tablets.

Wahbi, A. A. M., Hassan, E. M., Hamdy, D. A., Khamis, E. F., & Barary, M. H. (2005) · PubMed · Cited by 34 · see citing works

Severe dystrophic cardiomyopathy caused by the enteroviral protease 2A–mediated C-terminal dystrophin cleavage fragment

Barnabei, M. S., Sjaastad, F. V., Townsend, D., Bedada, F. B., & Metzger, J. M. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa4804 · Cited by 32 · see citing works

AMIODARONE INHIBITS INTERLEUKIN 6 PRODUCTION AND ATTENUATES MYOCARDIAL INJURY INDUCED BY VIRAL MYOCARDITIS IN MICE

Ito, H., Ono, K., Nishio, R., Sasayama, S., & Matsumori, A. (2002) · Cytokine · doi:10.1006/cyto.2001.0996 · Cited by 29 · see citing works

Link between enteroviruses and dilated cardiomyopathy: serological and molecular data

Keeling, P. J., & Tracy, S. (1994) · Heart · doi:10.1136/hrt.72.6_suppl.s25 · Cited by 28 · see citing works

The Role of B-Cells in Heart Failure

Cordero‐Reyes, A. M., Youker, K. A., & Torre‐Amione, G. (2013) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-9-1-15 · Cited by 27 · see citing works

Effect of delayed captopril therapy on left ventricular mass and myonecrosis during acute coxsackievirus murine myocarditis

Rezkalla, S. H., Kloner, R. A., Khatib, G., & Khatib, R. (1990) · American Heart Journal · doi:10.1016/0002-8703(90)90251-r · Cited by 27 · see citing works

Clinical Trials Update from the Heart Failure Society of America and the American Heart Association Meetings in 2008: SADHART-CHF, COMPARE, MOMENTUM, Thyroid Hormone analogue Study, HF-ACTION, I-PRESERVE, β-Interferon Study, BACH, and ATHENA

Coletta, A. P., Clark, A. L., & Cleland, J. G. F. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfn047 · Cited by 25 · see citing works

Cross-talk between cd1d-restricted nkt cells and γδ cells in t regulatory cell response

Liu, W., & Huber, S. A. (2011) · Virology Journal · doi:10.1186/1743-422x-8-32 · Cited by 24 · see citing works

Dilated Cardiomyopathy Risk in Patients with Coronavirus Disease 2019: How to Identify and Characterise it Early?

Komiyama, M., Hasegawa, K., & Matsumori, A. (2020) · European Cardiology Review · doi:10.15420/ecr.2020.17 · Cited by 22 · see citing works

Encephalomyocarditis virus myocarditis in inbred strains of mice. Chronic stage.

Matsumori, A., Kawai, C., & SAWADA, S. (1982) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.46.1192 · Cited by 21 · see citing works

Treatment‐refractory idiopathic hypereosinophilic syndrome: Pitfalls and progress with use of novel drugs

Bleeker, J. S., Syed, F. F., Cooper, L. T., Weiler, C. R., Tefferi, A., & Pardanani, A. D. (2012) · American Journal of Hematology · doi:10.1002/ajh.23120 · Cited by 18 · see citing works

Eosinophilic Myocarditis: Clinical Case and Literature Review

Dinis, P., Teixeira, R. P., Puga, L., Lourenço, C., Cachulo, M. C., & Gonçalves, L. M. M. (2018) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20180089 · Cited by 18 · see citing works

Immunoglobulin free light chains as an inflammatory biomarker of heart failure with myocarditis

Matsumori, A., Shimada, T., Nakatani, E., Shimada, M., Tracy, S., Chapman, N. M., Drayson, M. T., Hartz, V. L., & Mason, J. W. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108455 · Cited by 17 · see citing works

Cardiomyopathies and heart failure : biomolecular, infectious, and immune mechanisms

Matsumori, A. (2003) · Cited by 16 · see citing works

Severe Acute Respiratory Syndrome: Overview With an Emphasis on the Toronto Experience

Mazzulli, T., Kain, K. C., & BUTANY, J. W. (2004) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2004-128-1346-sarsow · Cited by 15 · see citing works

Immunomodulatory Effects of Mesenchymal Stromal Cells Revisited in the Context of Inflammatory Cardiomyopathy

Miteva, K., Linthout, S. V., Volk, H., & Tschöpe, C. (2013) · Stem Cells International · doi:10.1155/2013/353097 · Cited by 13 · see citing works

Response to Letters Regarding Article, “Clinical Profile and Influences on Outcomes in Patients Hospitalized for Acute Pericarditis”

Kytö, V., Sipilä, J., & Rautava, P. T. (2015) · Circulation · doi:10.1161/circulationaha.115.015505 · Cited by 3 · see citing works

COVID-19, Myocarditis and Pericarditis

Fairweather, D., Beetler, D. J., Di Florio, D. N., Musigk, N., Heidecker, B., & Cooper, L. T. (2023) · Circulation Research · doi:10.1161/circresaha.123.321878 · Cited by 181 · see citing works

Myocarditis and pericardial syndromes

Boffa, G., & Ceconi, C. (2019) · doi:10.1093/med/9780198759935.003.0017_update_001

Guías de manejo de enfermedad pericárdica y miocarditis

Marín, J. E., Duque, M., Uribe, W., & Medina, E. (2005) · SciELO Colombia- Scientific Electronic Library Online · Cited by 2 · see citing works

Pericarditis and myocarditis

Houghton, J. L. (1992) · Postgraduate Medicine · doi:10.1080/00325481.1992.11701212 · Cited by 8 · see citing works

Guías de manejo de enfermedad pericárdica y miocarditis Pericardial disease and myocarditis: management guide

Marín, J. E., Duque, M., Uribe, W., & Medina, E. (2005) · DOAJ (DOAJ: Directory of Open Access Journals)

Myocarditis and Pericarditis in Focus

Imazio, M., Cooper, L. T., Heidecker, B., Collini, V., Gröschel, J., Lazaros, G. A., Wang, T., Klein, A. L., Sinagra, G., & Schulz‐Menger, J. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.10.047 · Cited by 2 · see citing works